Jubilant Pharmova Q1 FY27 Financial Performance Review: Revenue Growth, Declining Profits
Jubilant Pharmova’s Q1 FY27 financial performance was mixed, with revenue increasing by 17% YoY to Rs 2,229 crore, but EBITDA decreasing YoY due to various factors. The company’s shares declined by 6% after the earnings announcement.